ArticleFrontiers in public health2026
Financial toxicity and its association with quality of life and psychological distress among patients with gynecologic cancers receiving radiotherapy in China: a multicenter cross-sectional study.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cancer Survivorship After COVID-19: Psychological Burden, Symptom Experience, and Social Support.Medicina (Kaunas, Lithuania) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Financial toxicity is increasingly recognized as a consequential dimension of cancer care, yet multicenter evidence in China remains limited for patients with gynecologic cancers undergoing radiotherapy, a treatment pathway that often entails repeated visits and substantial non-medical costs. This study estimated the prevalence and severity of financial toxicity and examined its association with quality of life and psychological distress. Methods: A multicenter cross-sectional survey was conducted in three tertiary hospitals in China, led by West China Second University Hospital, Sichuan University. Adult patients with gynecologic cancers receiving external beam radiotherapy and or brachytherapy with definitive, adjuvant, or curative-intent salvage or consolidation intent were consecutively recruited. Financial toxicity was assessed using the COmprehensive Score for financial Toxicity (COST, 0 to 44; lower scores indicate worse toxicity). Quality of life was measured using the EORTC QLQ-C30, and psychological distress using the Distress Thermometer (DT, 0 to 10; clinically significant distress defined as DT ≥ 4). Multivariable regression models included hospital fixed effects to account for measured differences across centers and adjusted for sociodemographic, access-burden, and clinical covariates. Results: Among 1,533 returned questionnaires, 1,303 were valid and analyzed (85.0%). Mean COST score was 21.6 (SD 7.4); 17.5% had severe financial toxicity (COST ≤ 14), 48.0% moderate (15 to 24), and 34.5% mild (≥25). Mean QLQ-C30 global health status was 61.3 (SD 14.2). Mean DT score was 4.3 (SD 2.1), and 65.2% met criteria for clinically significant distress. In adjusted analyses, each 5-point decrease in COST was associated with lower global health status (β -4.17, 95% CI -4.62 to -3.72), lower emotional functioning (β -4.68, 95% CI -5.20 to -4.16), higher fatigue (β 4.47, 95% CI 3.93 to 5.01), and higher DT score (β 0.32, 95% CI 0.23 to 0.40), all Conclusion: Financial toxicity was common among gynecologic radiotherapy patients in China and was independently associated with poorer quality of life and higher psychological distress. Integrating financial toxicity screening with supportive care pathways during radiotherapy may help identify high-risk patients and guide targeted assistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.